Tenex and Pepcid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tenex (guanfacine hydrochloride) and Pepcid (famotidine). Common drug interactions include pyrexia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Tenex and Pepcid. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Tenex?

Tenex has active ingredients of guanfacine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,865 Tenex users. Check the latest studies of Tenex.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.



On Jul, 26, 2026

22 people who take Tenex and Pepcid together, and have interactions are studied.

Tenex and Pepcid drug interactions.

What are the common drug interactions of Tenex and Pepcid, by gender? *:

female:

  1. Pyrexia (fever)
  2. Depression
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Hypotension (abnormally low blood pressure)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain
  7. Suicide attempt
  8. Dyspnoea (difficult or laboured respiration)
  9. Abdominal pain
  10. Adrenal disorder

male:

  1. Chronic kidney disease
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Anaphylactic reaction (serious allergic reaction)
  4. Bradycardia (abnormally slow heart action)
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Insomnia (sleeplessness)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Overweight
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Tenex and Pepcid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Injection site erythema (redness at injection site)
  2. Injection site pain
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Abdominal pain
  5. Aggression
  6. Agitation (state of anxiety or nervous excitement)
  7. Anger
  8. Arthralgia (joint pain)
  9. Chest pain
  10. Depression

20-29:

n/a

30-39:

  1. Adrenal disorder
  2. Adverse reaction
  3. Chills (felling of cold)
  4. Confusional state
  5. Cough
  6. Depression
  7. Drug ineffective
  8. Feeling drunk
  9. Headache (pain in head)
  10. Hip fracture

40-49:

  1. Chronic kidney disease
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Renal failure (kidney dysfunction)
  4. Hypertensive nephropathy (hypertensive renal disease)
  5. Nephropathy (damage to or disease of a kidney)
  6. Renal disorder (kidney disease)
  7. Renal impairment (severely reduced kidney function)
  8. Bradycardia (abnormally slow heart action)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

50-59:

  1. Eye haemorrhage (bleeding in the eye)
  2. International normalised ratio increased

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cytomegalovirus infection
  3. Haemoglobin decreased
  4. Hallucination, visual (seeing things that aren't there)
  5. Hypotension (abnormally low blood pressure)
  6. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  7. Hypovolaemia (a decreased volume of circulating blood in the body)
  8. Immunosuppression
  9. Nausea (feeling of having an urge to vomit)
  10. Neuralgia (pain in one or more nerves)

What are the existing conditions these people have? *

  1. Pain: 11 people, 50.00%
  2. Neuralgia (pain in one or more nerves): 8 people, 36.36%
  3. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 8 people, 36.36%
  4. Fluid Retention (an abnormal accumulation of fluid in the blood): 8 people, 36.36%
  5. Blood Pressure Abnormal: 6 people, 27.27%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.09%
  7. Drowsiness: 2 people, 9.09%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 9.09%
  9. Adrenocortical Insufficiency Acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Tenex and Pepcid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tenex and Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tenex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on guanfacine hydrochloride and famotidine (the active ingredients of Tenex and Pepcid, respectively), and Tenex and Pepcid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: